Quest Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. 

CEO
James E. Davis
CEOJames E. Davis
Employees
57,000
Employees57,000
Headquarters
Secaucus, New Jersey
HeadquartersSecaucus, New Jersey
Founded
1967
Founded1967
Employees
57,000
Employees57,000

DGX Key Statistics

Market cap
27.37B
Market cap27.37B
Price-Earnings ratio
23.10
Price-Earnings ratio23.10
Dividend yield
1.56%
Dividend yield1.56%
Average volume
1.23M
Average volume1.23M
High today
$233.21
High today$233.21
Low today
$223.42
Low today$223.42
Open price
$227.92
Open price$227.92
Volume
577.75K
Volume577.75K
52 Week high
$237.78
52 Week high$237.78
52 Week low
$165.78
52 Week low$165.78

Stock Snapshot

As of today, Quest Diagnostics(DGX) shares are valued at $228.58. The company's market cap stands at 27.37B, with a P/E ratio of 23.10 and a dividend yield of 1.56%.

During the trading session on 2026-07-24, Quest Diagnostics(DGX) shares reached a daily high of $233.21 and a low of $223.42. At a current price of $228.58, the stock is +2.3% higher than the low and still -2.0% under the high.

Trading volume for Quest Diagnostics(DGX) stock has reached 577.75K, versus its average volume of 1.23M.

The stock's 52-week range extends from a low of $165.78 to a high of $237.78.

The stock's 52-week range extends from a low of $165.78 to a high of $237.78.

DGX News

TipRanks 2h
Quest Diagnostics price target raised to $265 from $245 at BofA

BofA raised the firm’s price target on Quest Diagnostics (DGX) to $265 from $245 and keeps a Buy rating on the shares after the company reported “solid” Q2 resu...

Simply Wall St 7h
Is Quest Diagnostics Stock Still Worth More Than Its Price?

Quest Diagnostics stock has delivered a 79.9% return over the past three years, and the key question now is whether that strong run is still supported by the cu...

Is Quest Diagnostics Stock Still Worth More Than Its Price?
TipRanks 16h
Quest Diagnostics Lifts Outlook After Strong Earnings

Quest Diagnostics ((DGX)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful investing tools wit...

Analyst ratings

52%

of 21 ratings
Buy
47.6%
Hold
52.4%
Sell
0%

More DGX News

MarketWatch 20h
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Investor's Business Daily 22h
Hims, The Surprise Winner Of The FDA Showdown With Peptides, Bounds Higher

Quest Diagnostics Surges After Hims- And Oura-Tied Beat 3:09 AM ET Quest Diagnostics put up a definitive beat Thursday, driven by solid demand across its consu...

Hims, The Surprise Winner Of The FDA Showdown With Peptides, Bounds Higher
Benzinga 22h
Americans Are Buying More Preventive Health Tests—and Quest Diagnostics Is Winning

Earnings And Revenue Top Estimates Adjusted earnings rose to $3.12 per share, beating the analyst consensus estimate of $2.83. Revenue increased 10.2% year ove...

Americans Are Buying More Preventive Health Tests—and Quest Diagnostics Is Winning
Nasdaq 1d
Quest Diagnostics Surpasses Q2 Earnings and Revenue Estimates

Quest Diagnostics (DGX) came out with quarterly earnings of $2.30 per share, beating the Zacks Consensus Estimate of $2.23 per share. This compares to earnings...

Quest Diagnostics Surpasses Q2 Earnings and Revenue Estimates
Nasdaq 1d
Quest Diagnostics Q2 26 Earnings Conference Call At 8:30 AM ET

(RTTNews) - Quest Diagnostics (DGX) will host a conference call at 8:30 AM ET on July 23, 2026, to discuss Q2 26 earnings results. To access the live webcast,...

Quest Diagnostics Q2 26 Earnings Conference Call At 8:30 AM ET
Simply Wall St 5d
Quest Diagnostics Expands Oncology Test Access, Is The Stock Fully Valued?

Advertisement Why Quest Diagnostics Stock Is Back in Focus Quest Diagnostics (DGX) is back on investor watchlists after the company moved to integrate its Hay...

Quest Diagnostics Expands Oncology Test Access, Is The Stock Fully Valued?

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.